Sign In
Buy BCEL
$0.0900
+0 (+0%)
At Close: Sep 13, 2024
Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors
08:05pm, Monday, 26'th Aug 2019
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today announced the appointment of L
Another PTAB Casualty: Emmy Awarded Wireless Microphone Technology Could Be Invalidated
09:15pm, Tuesday, 13'th Aug 2019
On October 25, the AIPLA Annual Meeting will host a Patent Trial and Appeal Board (PTAB) Inter Partes Review (IPR) trial to determine the fate of a pair of patents issued by the U.S. Patent and Tradem
Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments
08:05pm, Tuesday, 13'th Aug 2019
REDWOOD CITY, Calif., Aug. 13, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
What It’s Like to Review Bitcoin's Code - CoinDesk
12:00pm, Friday, 19'th Jul 2019
CoinDesk dives deep into the complex process of reviewing code for the Bitcoin Core software.
Stifel: Atreca Offers Attractive Oncology Drug Development Play
06:22pm, Monday, 15'th Jul 2019
Atreca has a highly differentiated approach to antibody drug discovery that moves completely away from the biologically or genetically derived hypotheses that are traditionally used to inform target s
Atreca, Inc. (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today announced the appointment of Lisa L. Dec
Atreca Opens For Trade
03:16pm, Thursday, 20'th Jun 2019
Atreca, Inc. (NASDAQ: BCEL ) shares opened for trade Thursday morning at $19.90. The IPO of 7.35 million shares was priced at $17. Atreca is a biopharma company that uses its platform to discover and
Atreca Announces Pricing of Initial Public Offering
01:40am, Thursday, 20'th Jun 2019
REDWOOD CITY, Calif., June 19, 2019 -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel.
Thousands of Syrians flee last Isis territory with tales of horror
02:39pm, Tuesday, 29'th Jan 2019
In Deir ez-Zor, Richard Hall meets families fleeing from the once mighty caliphate, in its dying days
Editorial: Are you using your delivery services to drive loyalty? - eDelivery.net
07:03am, Wednesday, 17'th Oct 2018
Last week’s InternetRetailing Conference provided interesting food for thought when it comes to delivery – one of the key points being that done correctly delivery is the new loyalty. It was a cla
‘Four Walls’ With Rashida Jones Uses VR To Raise Awareness Of Refugee Crisis
11:30pm, Wednesday, 21'st Dec 2016
NPR predicts that the number of global refugees will surpass 60 million individuals by the end of this year. To put that in perspective, the entire state of California has a population of 39 millio
Coders Named After Harry Potter Characters Join Bitcoin’s 'Mimblewimble' - CoinDesk
05:54pm, Friday, 02'nd Dec 2016
One of bitcoin's more forward-looking projects has attracted a group of developers who are using some obscure names from the Harry Potter series.
Slack is killing email
03:00pm, Tuesday, 12'th Aug 2014
It’s been four years since Stewart Butterfield last sent an email to a work colleague. His team long ago replaced email with a chat app that plugged in to all their favorite services like Twitter,..
How to Write a Cover Letter
07:00pm, Tuesday, 04'th Feb 2014
Focus on why you’re right for the job and how badly you want it.
Litecoin founder Charles Lee on the origins of the cryptocurrency
12:05pm, Tuesday, 23'rd Jul 2013
Litecoin's creator Charles Lee is the secretive type - but he's happy to speak out about Mt. Gox, Bitcoin, and what's missing from his altcurrency.
